K

Kolltan Pharmaceuticals, Inc

9 employees

Kolltan Pharmaceuticals develops new-generation monoclonal antibody oncology therapeutics.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Medical
Pharmaceutical

Date founded

2007

Funding rounds raised

Total raised

$60M

from 10 investors over 10 rounds

K

Kolltan Pharmaceuticals, Inc raised $60M on March 19, 2014

Investors: Osage University Partners (OUP) and Purdue Pharma L.P.

K

Kolltan Pharmaceuticals, Inc raised $10M on January 20, 2010

Investors: Auven Therapeutics

K

Kolltan Pharmaceuticals, Inc raised $5M on October 12, 2009

Investors: Auven Therapeutics, Elm Street Ventures, Purdue Pharma L.P. and Osage University Partners (OUP)

K

Kolltan Pharmaceuticals, Inc raised $40M on July 31, 2008

Investors: Auven Therapeutics, Purdue Pharma L.P. and Osage University Partners (OUP)

FAQ